Tag Archives: case definition

IOM Panelists: The Knowns

In this post, we present profiles of the eight members of the Institute of Medicine ME/CFS definition panel who are known to the ME/CFS community in some capacity. Many, but not all, of them are ME/CFS experts in that they … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , | 24 Comments

IOM Panelists: The Unknowns

In this post, we present profiles of the seven members of the Institute of Medicine ME/CFS definition panel who were unknown to the ME/CFS community. You can read about the team who put this together and the methods we used … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , | 34 Comments

IOM Panelists: Method to Our Madness

My plan upon the announcement of the Institute of Medicine panel was to provide detailed write ups on all the members within 48 hours. Reality smacked me upside the head after about 24 hours. I am working with a wonderful … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , | 4 Comments

IOM Panel Announced

The Institute of Medicine has posted the provisional panel for public review and comment. I am working with a group of advocates to research all the members, seek out bias or conflicts of interest, and bring that information to you … Continue reading

Posted in Advocacy | Tagged , , , | 34 Comments

Which Disease Is HHS Studying?

I am very pleased to share space today with Mary Dimmock. She has written this guest post about which disease HHS has asked IOM to define. Her conclusion will probably increase any concerns you have about the IOM study. Mary … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , | 10 Comments

FAQchecking

So We Had Some Questions . . . For the last few weeks, there’s been a rumor that HHS might actually respond to questions about the Institute of Medicine study. PANDORA urged HHS to address specific questions about the contract … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , | 19 Comments

Quizzical

Update November 13, 2013: I have received a response from the CFIDS Association and have updated this post accordingly. Full comment from the Association below. My thanks to Carol Head, CEO of the CFIDS Association for her swift response to … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , | 15 Comments

IOM Conflict of Interest Policies

After my post on the basic process of an Institute of Medicine study, I received a number of questions in the comments and on Phoenix Rising about the definition of “conflict of interest” as distinguished from “bias.” I reached out … Continue reading

Posted in Advocacy | Tagged , , , , , | 54 Comments

IOM Process Check

Controversies continue to swirl around the Institute of Medicine’s study to create a clinical case definition for ME/CFS. I have new information to share, as well as important information about the process IOM uses for its studies. In preparing this … Continue reading

Posted in Advocacy | Tagged , , , , , | 38 Comments

CFSAC Profile: Dr. Gary Kaplan

The CFS Advisory Committee announced via its listserv on October 23, 2013 that Dr. Gary Kaplan has been appointed to the Committee. Kaplan brings an interesting point of view to the Committee, but advocates have reason to be concerned about … Continue reading

Posted in Advocacy | Tagged , , , , , , , , | 24 Comments